-
Mashup Score: 0Roche Plays for Bigger Stakes in Digital Pathology with Expanded AI Integration for Cancer Diagnostics - 10 month(s) ago
Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTr end.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy. Roche has announced an expansion of its Digital Pathology Open Environment, integrating over 20
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0Superluminal Medicines Raises $120 Million to Advance GPCR-Targeted Drug Discovery - 10 month(s) ago
Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy. Superluminal Medicines, Inc. has raised $120 million in a Series A funding round led by RA Capital
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet-
Superluminal Medicines Raises $120 Million to Advance GPCR-Targeted Drug Discovery https://t.co/6hOpZLY8aA https://t.co/W8tsZ9VfLc
-
-
Mashup Score: 0Six AI-driven Drug Discovery Companies Enabling Precision Oncology - 11 month(s) ago
Discover how AI is transforming precision oncology and advancing personalized cancer treatment. Learn about AI’s role in understanding complex biological systems, enhancing precision in immunotherapies, refining combination treatments, and optimizing clinical trials, with highlights on five innovative companies leading the way.
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet-
Six AI-driven Drug Discovery Companies Enabling Precision Oncology https://t.co/iBDBFEInzW https://t.co/zmRUUpenO9
-
-
Mashup Score: 0ThermoFace: Revealing Biological Age and Hidden Health Risks via Your Face's Heat Map - 11 month(s) ago
Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy. In a groundbreaking study published in Cell Metabolism in July 2024, researchers introduced
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet-
ThermoFace: Revealing Biological Age and Hidden Health Risks via Your Face's Heat Map https://t.co/gU60wGUDb4 https://t.co/g3XwukhL1U
-
-
Mashup Score: 0Bioptimus Introduces H-optimus-0: An Open-Source AI Model for Pathology - 12 month(s) ago
Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy. French startup Bioptimus has released H-optimus-0, the largest open-source AI foundation model for
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet-
Bioptimus Introduces H-optimus-0: An Open-Source AI Model for Pathology https://t.co/e7nDIa4mjU https://t.co/fHTGN8N5Yb
-
-
Mashup Score: 0Waypoint Bio Secures $14.5 Million to Advance Drug Discovery with Innovative In Vivo Spatial Pooled Screening Technology - 1 year(s) ago
Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com. Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy. Waypoint Bio, a biotechnology company focused on developing novel cell therapies for solid tumors,
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet-
Waypoint Bio Secures $14.5 Million to Advance Drug Discovery with Innovative In Vivo Spatial Pooled Screening Technology https://t.co/OhZF5k9ZC3 https://t.co/6PCAQHhQjm
-
-
Mashup Score: 0
The year 2012 is often regarded as the beginning of the deep learning revolution. That year, Alexnet, the deep learning model proposed in the research paper Imagenet Classification with Deep Convolutional Neural Network by Alex Krizhevs ky and his colleagues, won the large-scale visual recognition challenge ImageNet — completely dominating over other machine learning competitors. Scientists at Google’s mysterious X lab built a neural network of 16,000 computer processors with one billion connections,
Source: www.biopharmatrend.comCategories: General Medicine News, Future of MedicineTweet-
It’s Been a Decade of AI in the Drug Discovery Race. What’s Next? https://t.co/JFyesFGLrm https://t.co/YgXz8KQFSX
-
-
Mashup Score: 2Pharma’s Data Dilemma: How Machine-Learning Tools Hold the Key to Unlocking Novel Insights - 4 year(s) ago
Covid-19 is still having a devastating effect on many countries and economies worldwide and has brought to light the impact of diseases that affect some people in worse ways than others. With SARS-CoV-2, ethnicity, gender, age, and underlying health conditions all play a part in disease severity and mortality, but there is mounting evidence to…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet-
Pharma’s Data Dilemma: How Machine-Learning Tools Hold the Key to Unlocking Novel Insights https://t.co/Tcx1YEULhm https://t.co/cncbUcdUAe
-
-
Mashup Score: 0Tech Providers or Biotechs: The Quest to Find an Optimal Business Model Continues for AI Drug Discovery Companies… - 4 year(s) ago
The AI drug discovery industry has already gathered momentum with AI start-ups having signed more than 200 deals with 50+ pharma companies over the last few years, and these are just the disclosed deals. Few top companies like InSilico Medicine and Cyclica claim to have over 100 collaborations each with Academia and Industries. With billions of…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet-
Tech Providers or Biotechs: The Quest to Find an Optimal Business Model Continues for AI Drug Discovery Companies… https://t.co/8hZhLVQo9P https://t.co/obQZDeGtgw
-
-
Mashup Score: 0
Did you know? According to a study from Accenture, 60% of patients would prefer access to care via telehealth technology using digital communication tools than walking to a doctor’s office. The verdict is mounting that digital and telehealth communication is here to stay with us. Telehealth adoption has exploded since the onset…
Source: www.biopharmatrend.comCategories: Future of Medicine, Latest HeadlinesTweet-
How Digital Health Tools Will Transform Personalized Medicine in 2021 and Beyond? https://t.co/Nxxj5SVYoW https://t.co/Fvvct2fXLc
-
Roche Plays for Bigger Stakes in Digital Pathology with Expanded AI Integration for Cancer Diagnostics https://t.co/1KZ8DXsfXI https://t.co/N2ARZ1wKLE